CHICAGO, Sept. 14, 2017 -- Allscripts (NASDAQ:MDRX) is delivering an innovative first-to-market workflow solution that empowers clinicians and patients with complete information, at the point of care and in real time, to optimize the clinical and financial impact of prescription workflow. Allscripts is the first major healthcare information technology supplier to deliver such a solution.
Allscripts Real-Time Health System (RTHS) is launching a journey toward next-level patient care. The conceptual initiative aims to work with partner companies to enable technology that will deliver real-time information on:
- The medication price from the health plan or pharmacy benefit manager (PBM)
- The cash price
- What alternative therapies and their cost
- Competitive prices at different pharmacies
With multiple Payer/PBM and technology partners, Allscripts will focus on automatically embedding real-time prescription pricing information into the prescribing workflow, enabling healthcare providers to see what patients will pay for their medication at the point of care. Providers can then choose to communicate various savings methods and discounts based on their patients’ needs, increasing consumer knowledge and satisfaction, and improving the likelihood of medication adherence.
“This initiative ensures that physicians and their patients will have full knowledge of the price of medications and discounts available to them,” said Allscripts Senior Vice President and General Manager of Payer and Life Sciences, Jay Bhattacharyya. “Our recent partnerships with DrFirst, GoodRx and Surescripts give our providers coverage for nearly 100% of their patients and puts Allscripts at the forefront of delivering real-time benefit and price information, directly at the point of care.”
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Seth Frank
312-506-1213
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



